Image Analysis Group, Imaging Experts to Support Clinical Trials

NEWS

IAG will Attend IO360 in Boston, Massachusetts, 24 – 26 Mar

IAG is sponsoring and speaking at IO360. Schedule a meeting to connect.

Dr. Olga Kubassova to Deliver Keynote Lecture at the IBD Summitt

The President of IAG is invited to the 1st International Summit of Inflammatory Bowel Disease Monitoring.

Image Analysis Group Announces Release of DYNAMIKA V7

Image Analysis Group has released DYNAMIKA V.7, the award-winning cloud platform for clinical trial imaging. DYNAMIKA V.7 has achieved the British Standards Institute (BSI) surveillance audit certification following a recent SOC II Type I compliance certification.

IAG Wins in the 2024 Pharmaceutical Technology Excellence Awards

DYNAMIKA wins in the Innovation Category, supported by GlobalData.

IAG Appoints Jason Attanucci as Chief Commercial Officer

IAG today announced the appointment of Jason Attanucci as its new Chief Commercial Officer, where he will lead the company’s commercial strategy, focusing on strengthening client relationships, driving revenue growth, and expanding IAG’s market presence globally.

Dr Kubassova named one of the UK’s Most Ambitious Business Leaders

Recognized by the Times and LDC, London, 10 October 2024

IAG are Attending SCOPE Europe, Barcelona, 29-30 Oct

Meet our team at SCOPE Europe, 29-30 October 2024.

IAG Unveils Advanced AI Histology Tool for Clinical Research

Meet IAG at UEG and Scope 2024 to discuss imaging in your clinical trials.

VIEWS

FDA Guidance for Industry: Obesity and Overweight

Developing Drugs and Biological Products for Weight Reduction, with added imaging expertise

Embracing Digital Innovation in Digestive Disease Drug Development

Share IAG’s experience in using Medical Imaging and A.I. in early and late phase clinical trials.

The Transformative Power of AI in Oncology Drug Development

Share IAG’s experience in using Medical Imaging and A.I. in early and late phase clinical trials.

Bone Health: New Drugs vs New Tools

The field of bone health is undergoing unprecedented advancements, with novel imaging techniques deployed to take novel platforms through approvals.

Cartilage Repair: Imaging in Treatment Advancements

Critical Role of Imaging is Crucial in Drug Development

Getting approval: the EMA and the FDA

Thinking through drug approval: the FDA and EMA and their requirements.

Imaging Power in Alzheimer’s Disease (AD) Studies

Breakthroughs in AD research and trials rely on accurate imaging and its interpretation.

A Story started by our President, Dr Olga Kubassova

While studying for her PhD at Leeds, UK Olga Kubassova began work on commercialising her research.

Image Analysis Group (IAG)
IAG, a pioneering imaging Clinical Research Organization (iCRO), seamlessly blends medical acumen, operational excellence, and cutting-edge AI to accelerate drug development. Since 2007, we’ve been the trusted partner for global biotech and pharma, expertly managing imaging across Phase I-III trials and real-world evidence studies in diverse therapeutic areas.
Our award-winning DYNAMIKA platform ensures unparalleled data integrity, while our innovative approach consistently unlocks and amplifies the value of novel therapies.
Partner with IAG to transform your clinical trials and maximize your therapeutic asset’s market potential.

Email: imaging.experts@ia-grp.com

Will you use imaging to assess safety or efficacy of a new drug candidate?

* imaging strategy and endpoints
* site feasibility
* execution and data management
* working with your CRO
* use of AI and patient consent